Stock Events

Enzo Biochem 

€1
2
+€0+0% Friday 06:56

Statistics

Day High
1
Day Low
1
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
54.55M
P/E Ratio
1.22
Dividend Yield
-
Dividend
-

Earnings

13JunConfirmed
Q3 2022
Q3 2022
Q4 2022
Q1 2023
Q3 2023
Q4 2023
Q1 2024
-0.31
-0.22
-0.13
-0.04
Expected EPS
N/A
Actual EPS
-0.04

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EZB.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Qiagen NV
QGEN
Mkt Cap9.38B
Qiagen is a major player in the provision of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, directly competing with Enzo's life sciences products and diagnostic services.
Thermo Fisher Scientific
TMO
Mkt Cap206.16B
Thermo Fisher Scientific offers a broad range of reagents, instruments, and consumables used in biomedical research and diagnostics, overlapping with Enzo Biochem's market offerings.
Illumina
ILMN
Mkt Cap17.29B
Illumina provides sequencing and array-based solutions for genetic and genomic analysis, competing in the genomics space where Enzo also operates.
Bio-Rad Laboratories
BIO
Mkt Cap7.93B
Bio-Rad Laboratories manufactures and supplies products and systems used for gene expression, protein purification, and analysis, which are areas Enzo Biochem is involved in.
Quest Diagnostics
DGX
Mkt Cap15.6B
Quest Diagnostics is a provider of diagnostic testing, information, and services that competes with Enzo Biochem's diagnostic services segment.
Labcorp
LH
Mkt Cap0
Laboratory Corporation of America offers clinical laboratory tests and services, and end-to-end drug development services, competing with Enzo's diagnostic and research product offerings.
Agilent Technologies
A
Mkt Cap36.87B
Agilent Technologies provides instruments, services, consumables, applications, and expertise, focusing on life sciences, diagnostics, and applied chemical markets, competing with Enzo Biochem in several key areas.
Bruker
BRKR
Mkt Cap8.96B
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions that compete with Enzo Biochem's life science and diagnostic products.
Guardant Health
GH
Mkt Cap3.52B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing in the precision medicine and diagnostics space where Enzo Biochem is also aiming to grow.

About

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.
Show more...
CEO
Ms. Kara Cannon
Employees
179
Country
US
ISIN
US2941001024
WKN
000865607

Listings